Unknown

Dataset Information

0

Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.


ABSTRACT: Lymphopenia is considered one of the most characteristic clinical features of the coronavirus disease 2019 (COVID-19). SARS-CoV-2 infects host cells via the interaction of its spike protein with the human angiotensin-converting enzyme 2 (hACE2) receptor. Since T lymphocytes display a very low expression level of hACE2, a novel receptor might be involved in the entry of SARS-CoV-2 into T cells. The transmembrane glycoprotein CD147 is highly expressed by activated T lymphocytes, and was recently proposed as a probable route for SARS-CoV-2 invasion. To understand the molecular basis of the potential interaction of SARS-CoV-2 to CD147, we have investigated the binding of the viral spike protein to this receptor in-silico. The results showed that this binding is dominated by electrostatic interactions involving residues Arg403, Asn481, and the backbone of Gly502. The overall binding arrangement shows the CD147 C-terminal domain interacting with the spike external subdomain in the grove between the short antiparallel β strands, β1' and β2', and the small helix α1'. This proposed interaction was further confirmed using MD simulation and binding free energy calculation. These data contribute to a better understanding of the mechanism of infection of SARS-CoV-2 to T lymphocytes and could provide valuable insights for the rational design of adjuvant treatment for COVID-19. Communicated by Ramaswamy H. Sarma.

SUBMITTER: Helal MA 

PROVIDER: S-EPMC7544927 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.

Helal Mohamed A MA   Shouman Shaimaa S   Abdelwaly Ahmad A   Elmehrath Ahmed O AO   Essawy Mohamed M   Sayed Shireen M SM   Saleh Amr H AH   El-Badri Nagwa N  

Journal of biomolecular structure & dynamics 20200916 3


Lymphopenia is considered one of the most characteristic clinical features of the coronavirus disease 2019 (COVID-19). SARS-CoV-2 infects host cells via the interaction of its spike protein with the human angiotensin-converting enzyme 2 (hACE2) receptor. Since T lymphocytes display a very low expression level of hACE2, a novel receptor might be involved in the entry of SARS-CoV-2 into T cells. The transmembrane glycoprotein CD147 is highly expressed by activated T lymphocytes, and was recently p  ...[more]

Similar Datasets

| S-SCDT-EMM-2022-15904 | biostudies-other
| S-EPMC8386461 | biostudies-literature
| S-EPMC10418891 | biostudies-literature
| S-EPMC7801465 | biostudies-literature
| S-EPMC8674568 | biostudies-literature
| EMPIAR-10947 | biostudies-other
| S-EPMC8250905 | biostudies-literature
| S-EPMC7889469 | biostudies-literature
| S-EPMC7714896 | biostudies-literature
| S-EPMC8694004 | biostudies-literature